Skip to main content

Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding

Basic Details
Date Posted
Status
Complete
Medical Product
inhaled corticosteroids
montelukast
Health Outcome(s)
intentional self-harm
Description

This analysis describes the characteristics of patients dispensed montelukast or inhaled corticosteroids and evaluates the subsequent risk of intentional self-harm identified using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes in the Sentinel Distributed Database. This analysis was conducted as an update to a previous Sentinel study that used International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes to identify intentional self-harm events. The study period includes data from October 1, 2015 to June 30, 2022. We distributed this request to six Sentinel Data Partners on December 21, 2022.

The analytic package associated with this analysis can be found externally in Sentinel's Git Repository located here. The Git Repository serves as Sentinel's version control tracking system for analytic packages and technical documentation.

Deliverables (2)
Sentinel Analytic Package: Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding Sentinel Modular Program Report: Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding
Additional Details
FDA Center
CDER
Time Period
October 1, 2015 – June 30, 2022
Analysis Type
Retrospective Inferential
Population / Cohort
Individuals 10 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Singulair (Montelukast) & Intentional Self-Harm
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding"